Erasmus University Medical Centre, Rotterdam (Netherlands (The))
Member of:
In 2011 she started her Master Advanced Nursing Practice (MANP) en completed this study in 2013. From this time she worked as a nurse practitioner in care for patient with familial hypercholesterolemia (FH), combined with research in this population. In 2018 she finished her PhD. Since 2015 she is president of the nurse practitioners in the Erasmus MC, the Netherlands.
Real world experience of efficacy and safety using Proprotein convertase subtilisin / Kexin 9 (PCSK9) inhibition in patients with familial hypercholesterolemia
Event:
EuroHeartCare 2017
Topic:
Prevention and rehabilitation from knowledge to practice
Session:
Prevention and rehabilitation from knowledge to practice
Real world experience of efficacy and safety using proprotein convertase subtilisin / Kexin 9 (PCSK9) inhibition in patients with Familial Hypercholesterolemia